Lori J. Gabryelski

3.5k total citations · 2 hit papers
16 papers, 2.2k citations indexed

About

Lori J. Gabryelski is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Lori J. Gabryelski has authored 16 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Virology and 7 papers in Molecular Biology. Recurrent topics in Lori J. Gabryelski's work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (12 papers) and Biochemical and Molecular Research (7 papers). Lori J. Gabryelski is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (12 papers) and Biochemical and Molecular Research (7 papers). Lori J. Gabryelski collaborates with scholars based in United States. Lori J. Gabryelski's co-authors include William A. Schleif, Daria J. Hazuda, Peter J. Felock, Kara A. Stillmock, Marc Witmer, Abigail Wolfe, Michael D. Miller, Amy S. Espeseth, Jay A. Grobler and Emilio A. Emini and has published in prestigious journals such as Nature, Science and Journal of Medicinal Chemistry.

In The Last Decade

Lori J. Gabryelski

16 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

2000 922 citations Daria J. Hazuda, Peter J. Felock et al. Science profile →
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1995 810 citations Jon H. Condra, William A. Schleif et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori J. Gabryelski United States	12	1.8k	1.6k	718	464	268	16	2.2k
Marc Witmer United States	15	1.9k 1.1×	1.7k 1.0×	1.1k 1.5×	391 0.8×	311 1.2×	20	2.4k
J C Quintero United States	13	1.7k 1.0×	1.6k 1.0×	529 0.7×	352 0.8×	280 1.0×	19	2.3k
Yasuhiro Koh United States	27	1.7k 0.9×	1.6k 1.0×	787 1.1×	562 1.2×	383 1.4×	40	2.4k
Sudthida Vasavanonda United States	16	1.5k 0.9×	1.3k 0.8×	488 0.7×	481 1.0×	217 0.8×	27	2.1k
Kara A. Stillmock United States	13	1.4k 0.8×	1.2k 0.7×	776 1.1×	364 0.8×	234 0.9×	16	1.8k
Jill C. Heimbach United States	7	1.6k 0.9×	1.5k 0.9×	958 1.3×	423 0.9×	203 0.8×	10	2.3k
William E. Kohlbrenner United States	19	924 0.5×	695 0.4×	774 1.1×	521 1.1×	353 1.3×	34	1.9k
Karen A. Kirby United States	26	1.2k 0.7×	1.1k 0.6×	585 0.8×	249 0.5×	424 1.6×	61	1.8k
Hilde Azijn Belgium	16	2.1k 1.2×	1.9k 1.1×	341 0.5×	276 0.6×	469 1.8×	20	2.4k
Michael J. Kukla United States	19	1.4k 0.8×	1.2k 0.7×	663 0.9×	797 1.7×	350 1.3×	44	2.2k

Countries citing papers authored by Lori J. Gabryelski

Since Specialization

Citations

This map shows the geographic impact of Lori J. Gabryelski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori J. Gabryelski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori J. Gabryelski more than expected).

Fields of papers citing papers by Lori J. Gabryelski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori J. Gabryelski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori J. Gabryelski. The network helps show where Lori J. Gabryelski may publish in the future.

Co-authorship network of co-authors of Lori J. Gabryelski

This figure shows the co-authorship network connecting the top 25 collaborators of Lori J. Gabryelski. A scholar is included among the top collaborators of Lori J. Gabryelski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori J. Gabryelski. Lori J. Gabryelski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Melamed, Jeffrey Y., Melissa S. Egbertson, Sándor Varga, et al.. (2008). Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase. Bioorganic & Medicinal Chemistry Letters. 18(19). 5307–5310. 20 indexed citations

Williams, Peter, Carl F. Homnick, Joseph P. Vacca, et al.. (2007). Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 721–725. 13 indexed citations

Wolkenberg, S. E., Meiqing Lu, Vandna Munshi, et al.. (2007). Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bioorganic & Medicinal Chemistry Letters. 18(2). 554–559. 76 indexed citations

Raghavan, Subharekha, Zhijian Lu, Kevin T. Chapman, et al.. (2007). Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus. Bioorganic & Medicinal Chemistry Letters. 17(19). 5432–5436. 8 indexed citations

Wai, John, Bo Young Kim, Thorsten E. Fisher, et al.. (2007). Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(20). 5595–5599. 21 indexed citations

Fisher, Thorsten E., Bo-Young Kim, Terry A. Lyle, et al.. (2007). 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(23). 6511–6515. 31 indexed citations

Guare, James P., John Wai, Robert Gomez, et al.. (2006). A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(11). 2900–2904. 37 indexed citations

Lu, Zhijian, Carrie A. Rutkowski, David B. Olsen, et al.. (2005). Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus. Bioorganic & Medicinal Chemistry Letters. 15(23). 5311–5314. 8 indexed citations

Zhuang, Linghang, John Wai, Mark W. Embrey, et al.. (2003). Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells. Journal of Medicinal Chemistry. 46(4). 453–456. 219 indexed citations

10.

Lu, Zhijian, Subharekha Raghavan, Mark G. Charest, et al.. (2003). Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus. Bioorganic & Medicinal Chemistry Letters. 13(10). 1821–1824. 12 indexed citations

11.

Cheng, Yuan, Fengqi Zhang, Thomas A. Rano, et al.. (2002). Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains. Bioorganic & Medicinal Chemistry Letters. 12(17). 2419–2422. 23 indexed citations

12.

Raghavan, Subharekha, Zheng Rong Yang, Ralph T. Mosley, et al.. (2002). Combinatorial library of indinavir analogues: replacement for the aminoindanol at P2′. Bioorganic & Medicinal Chemistry Letters. 12(20). 2855–2858. 6 indexed citations

13.

Cheng, Yuan, Thomas A. Rano, Fengqi Zhang, et al.. (2002). A Combinatorial Library of Indinavir Analogues and Its In Vitro and In Vivo Studies. Bioorganic & Medicinal Chemistry Letters. 12(4). 529–532. 6 indexed citations

14.

Rano, Thomas A., Yuan Cheng, Fengqi Zhang, et al.. (2000). Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library. Bioorganic & Medicinal Chemistry Letters. 10(14). 1527–1530. 15 indexed citations

15.

Hazuda, Daria J., Peter J. Felock, Marc Witmer, et al.. (2000). Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells. Science. 287(5453). 646–650. 922 indexed citations breakdown →

16.

Condra, Jon H., William A. Schleif, Lori J. Gabryelski, et al.. (1995). In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 374(6522). 569–571. 810 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact